Table 2.
Prognostic analysis of the six-FBXOs in GEPIA and Kaplan–Meier plotter.
| Genes | Expression | GEPIA | Kaplan–Meier plotter | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OS | DFS | OS | RFS | ||||||
| HR (high) | p-value | HR (high) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | ||
| FBXO1 (CCNF) | Upregulated | 1.6 | 0.024 | 1.4 | 0.098 | 1.73 (1.13–2.63) | 0.0102 | 3.31 (1.12–9.79) | 0.0224 |
| FBXO20 (LMO7) | Upregulated | 1.7 | 0.012 | 1.6 | 0.033 | 2.73 (1.54–4.83) | 0.0004 | 9.60 (2.24–41.23) | 0.0002 |
| FBXO22 | Upregulated | 2.0 | 0.0014 | 1.6 | 0.037 | 2.07 (1.23–3.47) | 0.0048 | 2.77 (0.93–8.21) | 0.0561 |
| FBXO28 | Upregulated | 1.6 | 0.026 | 1.6 | 0.026 | 1.78 (1.17–2.72) | 0.0068 | NA | 0.0035 |
| FBXO32 | Upregulated | 1.5 | 0.048 | 1.6 | 0.051 | 1.71 (1.13–2.61) | 0.0110 | 3.20 (1.38–7.42) | 0.0045 |
| FBXO45 | Upregulated | 1.7 | 0.013 | 1.7 | 0.015 | 1.99 (1.30–3.05) | 0.0012 | 3.15 (1.36–7.30) | 0.0050 |
OS, overall survival; DFS, disease-free survival; RFS, relapse-free survival; HR, hazard ratio; CI, confidence interval; NA, not available.